| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8959182 | Transplantation Proceedings | 2018 | 13 Pages |
Abstract
Kallistatin among heart transplant recipients does not seem to be the pathogenetic factor of arterial hypertension but may be involved in the development of hyperlipidemia often present in this group of patients.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
P. PrzybyÅowski, G. Wasilewski, E. Koc-Å»órawska, J. MaÅyszko,